HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Peter Schirmacher Selected Research

B7-H1 Antigen

11/2019Multicentric analytical comparability study of programmed death-ligand 1 expression on tumor-infiltrating immune cells and tumor cells in urothelial bladder cancer using four clinically developed immunohistochemistry assays.
2/2018Interlaboratory concordance of PD-L1 immunohistochemistry for non-small-cell lung cancer.
10/2016Harmonized PD-L1 immunohistochemistry for pulmonary squamous-cell and adenocarcinomas.
1/2016Pan-cancer analysis of copy number changes in programmed death-ligand 1 (PD-L1, CD274) - associations with gene expression, mutational load, and survival.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Peter Schirmacher Research Topics

Disease

219Neoplasms (Cancer)
06/2022 - 10/2002
60Hepatocellular Carcinoma (Hepatoma)
10/2020 - 10/2002
30Colorectal Neoplasms (Colorectal Cancer)
01/2022 - 11/2005
29Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2022 - 04/2007
28Neoplasm Metastasis (Metastasis)
06/2022 - 09/2008
23Carcinogenesis
11/2020 - 10/2003
21Liver Neoplasms (Liver Cancer)
01/2022 - 01/2007
20Adenocarcinoma
06/2022 - 08/2003
18Fibrosis (Cirrhosis)
10/2021 - 01/2006
17Carcinoma (Carcinomatosis)
06/2022 - 08/2003
16Inflammation (Inflammations)
10/2021 - 05/2002
15Cholangiocarcinoma
06/2022 - 01/2006
15Liver Diseases (Liver Disease)
10/2021 - 01/2006
13Renal Cell Carcinoma (Grawitz Tumor)
01/2020 - 01/2009
12Lung Neoplasms (Lung Cancer)
11/2021 - 05/2009
10Breast Neoplasms (Breast Cancer)
01/2022 - 02/2008
10Sclerosing Cholangitis
08/2019 - 01/2006
9Hepatitis
01/2020 - 07/2004
8Pancreatic Neoplasms (Pancreatic Cancer)
01/2022 - 01/2007
8Sarcoma (Soft Tissue Sarcoma)
01/2019 - 11/2012
8Infections
01/2018 - 09/2006
7Adenocarcinoma of Lung
02/2022 - 05/2011
7Melanoma (Melanoma, Malignant)
01/2022 - 01/2009
6Disease Progression
01/2022 - 02/2018
6Microsatellite Instability
11/2021 - 02/2010
6Biliary Tract Neoplasms (Biliary Tract Cancer)
11/2020 - 02/2014
6Liver Cirrhosis (Hepatic Cirrhosis)
01/2019 - 09/2006
5Adenoma (Adenomas)
12/2021 - 11/2005
5Hepatolenticular Degeneration (Wilson's Disease)
10/2018 - 01/2012
5Brain Neoplasms (Brain Tumor)
01/2018 - 06/2007
5Thymoma (Thymic Carcinoma)
05/2014 - 11/2006
4Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2022 - 03/2009
4Prostatic Neoplasms (Prostate Cancer)
01/2022 - 01/2017
4AIDS-Related Complex (ARC)
12/2021 - 05/2016
4Hypoxia (Hypoxemia)
10/2021 - 01/2013
4Cholestasis
10/2021 - 10/2008
4Pathologic Constriction (Stenosis)
08/2019 - 02/2011
4Liposarcoma
01/2019 - 11/2012
4Fatty Liver
12/2015 - 01/2008
3Virus Diseases (Viral Diseases)
08/2022 - 10/2005
3Chromosomal Instability (Chromosome Stability)
01/2022 - 06/2012
3Gastrointestinal Neoplasms (Gastrointestinal Cancer)
01/2022 - 06/2013

Drug/Important Bio-Agent (IBA)

64Proteins (Proteins, Gene)FDA Link
12/2021 - 11/2005
26Biomarkers (Surrogate Marker)IBA
01/2022 - 01/2011
25ParaffinIBA
01/2022 - 09/2006
24Formaldehyde (Formol)FDA Link
01/2022 - 07/2007
19DNA (Deoxyribonucleic Acid)IBA
08/2021 - 06/2007
18Immune Checkpoint InhibitorsIBA
02/2022 - 11/2016
15Biological ProductsIBA
01/2020 - 06/2008
15Messenger RNA (mRNA)IBA
01/2017 - 12/2004
13RNA (Ribonucleic Acid)IBA
08/2022 - 06/2015
11Pharmaceutical PreparationsIBA
01/2022 - 06/2008
11Phosphotransferases (Kinase)IBA
01/2020 - 03/2008
10Tyrosine Kinase InhibitorsIBA
01/2022 - 10/2008
8ErbB Receptors (EGF Receptor)IBA
01/2021 - 04/2007
8Cyclooxygenase 2 (Cyclooxygenase-2)IBA
10/2020 - 10/2002
7CateninsIBA
12/2021 - 03/2011
7Carrier Proteins (Binding Protein)IBA
12/2020 - 11/2007
7MicroRNAs (MicroRNA)IBA
11/2020 - 04/2008
7CytokinesIBA
10/2020 - 08/2003
7Anaplastic Lymphoma KinaseIBA
01/2019 - 07/2012
6LigandsIBA
04/2021 - 01/2009
6Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA
10/2020 - 07/2004
6Sorafenib (BAY 43-9006)FDA Link
09/2018 - 10/2013
6Antiviral Agents (Antivirals)IBA
09/2017 - 10/2005
6Transforming Growth Factor beta (TGF-beta)IBA
02/2014 - 05/2002
5Cadherins (E-Cadherin)IBA
06/2022 - 10/2003
5Interleukin-6 (Interleukin 6)IBA
02/2022 - 03/2007
5pembrolizumabIBA
11/2021 - 09/2017
5CollagenIBA
10/2020 - 09/2006
5EnzymesIBA
01/2020 - 06/2006
5Death Domain ReceptorsIBA
12/2019 - 07/2006
5Cisplatin (Platino)FDA LinkGeneric
11/2019 - 09/2007
5Phenobarbital (Luminal)FDA Link
03/2019 - 03/2012
5Keratins (Keratin)IBA
03/2019 - 06/2006
5Epithelial Cell Adhesion MoleculeIBA
08/2017 - 01/2006
5Small Interfering RNA (siRNA)IBA
01/2017 - 09/2007
5Transcription Factors (Transcription Factor)IBA
01/2017 - 07/2012
5ElementsIBA
03/2016 - 03/2009
5Insulin-Like PeptidesIBA
05/2014 - 03/2004
4beta CateninIBA
01/2022 - 10/2003
4Bile Pigments (Bilin)IBA
11/2020 - 06/2017
4Transaminases (Aminotransferases)IBA
01/2020 - 02/2010
4StathminIBA
11/2019 - 09/2007
4B7-H1 AntigenIBA
11/2019 - 01/2016
4Perilipin-2IBA
01/2019 - 03/2010
4Long Noncoding RNAIBA
11/2018 - 08/2012
4RNA-Binding Proteins (RNA-Binding Protein)IBA
11/2018 - 08/2012
4Hormones (Hormone)IBA
05/2018 - 01/2009
4InterferonsIBA
09/2017 - 09/2004
4Insulin-Like Growth Factor II (Somatomedin A)IBA
07/2008 - 03/2004
3Complementary DNA (cDNA)IBA
12/2021 - 09/2004
3ChemokinesIBA
10/2020 - 02/2011

Therapy/Procedure

78Therapeutics
06/2022 - 10/2005
20Drug Therapy (Chemotherapy)
01/2022 - 03/2004
11Immunotherapy
12/2021 - 01/2006
11Liver Transplantation
01/2016 - 01/2006
8Transplantation
03/2020 - 01/2006
5Neoadjuvant Therapy
07/2021 - 04/2010
5Precision Medicine
07/2021 - 01/2016